Company: MYSEW
Filing Date: 2025-02-10
Form Type: 424B5
Source: 0001213900-25-011767
Chunk: 15

Company: Myseum, Inc.
Filing Date: 2025-02-10
Form: 424B5
Chunk 15
---
 Factors” beginning on page S-8 of this prospectus, the accompanying prospectus, and in our Form 10-K for the year ended December 31, 2024, and in any updates to those risk factors in our reports on Form 10-Q or subsequent filings, incorporated by reference into this prospectus for a discussion of factors you should carefully consider before deciding to invest in our common stock.                                                               |
| Nasdaq Capital Market symbol:                                   | DATS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

The number of shares of our common stock outstanding before this offering and to be outstanding immediately after this offering is based on 4,209,329 shares of our common stock issued and outstanding as of February 10, 2025, and excludes the following:

| ● | 140,570                                                                                         
 shares of our common stock issuable upon the exercise of stock options outstanding under        
 our 2021 Omnibus Equity Incentive Plan as of September 30, 2024, at a weighted-average exercise 
 price of $114.65 per share;                                                                     |

| ● | 459,430                                                                                     
 shares of common stock reserved for future issuance under our 2021 Omnibus Equity Incentive 
 Plan; and                                                                                   |

| ● | 67,385                                                                                        
 shares of our common stock issuable upon the exercise of outstanding warrants as of September 
 30, 2024, at a weighted-average exercise price of $49.80 per share.                           |

<div align='center'>S-7

RISK FACTORS</div>

Our Annual Report on Form 10-K for the year ended December 31, 2023, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, which are incorporated by reference into this prospectus supplement, as well as our other filings with the SEC, include material risk factors relating to our business. Those risks and uncertainties and the risks and uncertainties described below are not the only risks and uncertainties that we face. Additional risks and uncertainties that are not presently known to us or that we currently deem immaterial or that are not specific to us, such as general economic conditions, may also materially and adversely affect our business and operations. If any of those risks and uncertainties or the risks and uncertainties described below actually occurs, our business, financial